Council for Tobacco Research
From Atom to Eve Reprinted From Perspectives in Biology and Medicine Vol. 24 No. 2 [St Discusses Jacobson]
Abstract
MAR
Fields
- Type
- SCIENTIFIC ARTICLE
- BIBLIOGRAPHY
- Master ID
- Hk2290037-0059
- Request
- 131
- Depository Date
- 15 May 1996
- Named Person
- Hockett, B.
- Jake
- Perspectives, I.N. Biology And Medicine
- Billings Hospital
- Univ, C.A. Berkeley
- Oberlin College
- Corps, O.F. Engineers
- Dupont
- Sloan Kettering Memorial Hospital
- Michael Reese Hospital
- Nci
- Cancer Inst Bethesda
- Us Off, O.F. Scientific Research And Development
- Yale Univ
- Assn, O.F. Amer Physicians
- Allen, J.G., Metallurgical Laboratory
- Bachmeyer, A., Univ Chicago
- Barron, E.S.
- Bloom, W.
- Brues, A., Argonne Natl Laboratory
- Cantril, S., Swedish Hospital Seattle
- Cole, K., Columbia Univ
- Compton, A., Univ Chicago
- Conant, Univ Chicago
- Craver, L., Memorial Hospital, N.Y.
- Creutz, E.
- Curtis, H.J., Hopkins Aviation
- Deringer, M.
- Dick, G., Univ Chicago
- Doniger, J.
- Dougherty, T.
- Dunne, T.
- Einstein, Univ Chicago
- Eschenbrenner, A.
- Fermi, E., Univ Chicago
- Friedell, H., Army Manhattan Engg
- Fussler, H.
- Gilman, A.
- Golden, R., Columbia Univ
- Goodman, L.S.
- Hagen, C.
- Hamilton, J., Univ Chicago
- Hamilton, J., Univ, C.A. Berkeley
- Heston, W.
- Hilberry, N., Univ Chicago
- Hodges, P., Univ Chicago
- Hogness, Met Lab
- Hutchens, J.
- Hutchins, R., Univ Chicago
- Kimpton, L., Met Lab
- Latimer, Univ, C.A.
- Lawrence, E.O., Univ, C.A. San Francisco
- Leverett, M.
- Lindskog, G.
- Lorenz, E.
- Lushbaugh, C.
- Marks, E.K., Met Lab
- Mclean, F.
- Moore, T.
- Mulliken, R.
- Nickerson, M.
- Nickson, J.
- Patt, H., Argonne Natl Laboratory
- Robertson, O.H.
- Rosenwald
- Sachs, Univ Chicago
- Seaborg, G., Met Lab
- Shimkin, M.
- Simmons, E.
- Spurr, C.
- Stone, R., Univ, C.A. San Francisco
- Svikla, G.
- Szilard, L., Univ Chicago
- Taliaferro, W., Univ Chicago
- Truman, U.S.
- Warren, S., Univ Rochester
- Watson, C.J., Univ, M.N.
- Woods, L., Met Lab
- Young, H.
- Zirkle, R., I.N. Univ
- Jake
- Author
- Jacobson, L.O., Univ Chicago
- Box
- 172
- UCSF Legacy ID
- igt20a00
Document Images
N14®22900S7
! v
/A Z7,7-
i
~
FROM ATOM TO EVE
J
)
by
LEON O. JACOBSON
Reprioted From: Perspectlvo In Biobgy aod Mcdkine
Vdnme 2A Namber 2 Wioter 1981

NK12290038
FROM ATOM TO EYE*
LEON 0 fACOBSONt
In the Beginning
In January of 10421 was an assistant in the Department of Medicine at
the University of Chicago. One afternoon I was helping an intern
catheterize a patient with a "watering pot perineum." This descriptive
phrase applies to an individual who has active tuberculosis of the bladder
with multiple fistulae that lead from the bladder through to the skin in
the perineum and lower buttocks. No antibiotics were available for the
treatment of tuberculosis, and since such patients were highly infectious,
the nurse, the intern, and I were all properly gowned, masked, and
rubber-gloved to protect otdrselves as well as the patient.
During this medical protedure. I heard my name being called re-
peatedly over the t.elepage, indicating an emergency. Since we had now
completed our catheterization. I hurriedly removed my gown, scrubbed
my hands, and went to the nursing station. The message from telepage'
had been taken-it was simply, "Repon to the dean immediately." As a
medical student and later as a house officer, I had never had any contact
with the dean g office, but I knew that William Taliaferro was the dean,
for his face graced the center of every medical class picture on the walls
of Billings Hospital corridors. At that moment in my mind's eye I saw
him with a stern and sinister look. ,
As I hurried to the dean's office, I wondered if I had done something
wr7ng. Was I behind in summarizing the patients' charts at discharge or
death? Was there a complaint from a patient or patients I might some-
how have failed to please? Was my chief of medicine dissatisfied with my
performance? There were other thoughts darting in and out of my mind
since. For the life of me, I could not imagine why Dean Taliaferro would
want to see me.
I arrived at the dean's office and told the secretary who I was. She
knocked on the dean's rbsed door and ushered me in. There sat Itean
*Read in part to a private interdisciplinary social club (Stochastics) at the University of
Chicago. February 1979.,
tEmeritus profesmr, Ilepartment of Medikine, Joseph Regenstein pmfessor, Biological
and Medical Sciences. University of Chicago.
® 1981 by The Univetsity of Chicago. OOs 1-598281/2402-04Y9S01.00
Pmpertivrs in Biology snd Medkine ' Wint.r 1981 I 195
i

NK12290039
Taliaferro, Dr. George Dick (Chairman of Medicine), Dr. Arthur
Bachmeyer (Director of Hospitals and Clinics), Dr. Paul Hodges (Chief
of Radi'olugy). and two men I had never laid eyes on before. By now my
respiratory rate had doubled, my heart was racing at least 125 beats per
rninute: and my mind was muddled up with vague fears and conjectures.
"Hcllo, Leon. You know Dr. Dick, Dr. Bachmeyer, and Dr. Hodges, of
course; meet Professor Wollah and Professor Hilberry. Please have a
chair. Leon," he said after we were all seated, "Mr. Hilberry and Mr.
Wollan are from the Physics Department. Dean Arthur Compton has
talked with Dr. Dick, Dr. Robertson, Dr. Hodges. Dr. Bachmeyer; and
me, and we have decided that ~ou are the one they need to help them
with a special problem they are having in their research." How could I
help C:ompton and his physics group? I thought. Taliaferro continued.
"They are doing research with penetrating radiations produced by the
cyclotron, as well as with radioactive substances. They need someone
who is aphysician aud who knows the bloodforming tissue as you do. to
keep careful tabs on those who are or may be exposed to these hazards."
George Dick and O. H. Robertson were aware of my research on
estrogen effects on the bone anarnow, the clinical use of radiophos-
phorus' for treatment of the leukcmias, research on pernicioas anemia,
and the like. Perhaps, I thought, they can't find anyone else, so they have
decided I'm it--sounds like routine stuff to me.
George Dick looked at me through his penetrating eyes and said,
"Your suiroeillance of these scientists will be an exciting adventure in
prevenu4e medicine and closely related to your snecial interests in blood
and blood-form:ng tissue. Professors Wollan and Hilberry will give you
the background. but I assure you that the work they are doing is essential
to the war effort and yourgartieipation in their program is essential to
its progreas."
What could I say?. I'm sure I had been signed, sealed, and delivered
before I even got to the dean's ofl'ice. So I came up with -the dich "e--
"Thank you, I71 be glad to hear more details and will try to do my best."
The cotiversation' continued, with Wollan and Hilberry saying a few
words about the human hazards involved in their work. Bachmeyer
stating that a laboratory and clinic space would be made available, and
Taliaferro mentioning the relationship of radiation injury to immune
suppression=and everyone stood up. I mumbled something like,
"Thanks, it all sounds interesting." Wollan and Hilberry and I left the
dean's office together and walked up to the third floor of $illings, where
I shared an office with four cages of mice on which I was conducting an
'I did this r!esearch in collaboration with Louis Slopn, who provided the radiophos
phwus'sp produced m the cyclotron. Dr. Slotin. who lefl the htetallurgical laboratory to
join the t.os Alamos staff, was the second individual to succumb to a nuclear accident: this
accident occurired 'ni late 1945 atter the Nagasaki and Hiroshima detonations.
196 1 Lron t). faroDn.on Frrom .imom to E:w

HK12290040
experiment. There the briefing began, but it lasted only 15 minutes. I
had many questions, and they gave evasive answers to some of them.
Finally, they said ihey had to leave because of experiments in p'rogrrss,
but I'm quite sure that it was the essence of mice in the room that
shortened the briefirdg time. S'oon thereafter, I met them for further
information in Eckhart Hall in Wollan's office. The office had a musty
smell and I added another ingredient, the smell of mice.
I had taken physics, and advanced math in college. The former I shall
never forget; I missed the first semester of the physics sequence because
of a ruptured appendbx. I enrolled with the engineering students for the
second sequence in physics, green as green. As far as I can remember, it
is the only course that ever drove rne up a wall. I just didn't get the pitch.
After the final ex~m, my professor called me in. He wore a long face,
and the mofirtent I saw him, my physiognomy resembled his. He told me
I had done poorly on the exam. But as we talked, his face softened. In
fact, the more we talked, the more enthusiastic and frien*lly he became. I
soon found out why-=-he would give me a passing grade in physics if I
agreed to become a niedical missionary. I never went to Africa, as I'm
sure he had in mii{d, but I've kept the promise and preached medicine
and meflical sciench every day of my life since that interview. By the way.
I had no probiem with the next semester course in physics.
While I.+as in med~al school, Dr. Paul Hodges selected me to do the
radiography for variotts scientists who were using experimental animals
to study diseases like pneumonia and tuberculosis. I developed the films
and reported the results as well. In the same room under the supervision
of Dr. Jane Hamilkon from the Department of Physics was an X-ray
therapy machine for dudies on the biological effects of radiation; with
Dr. Hamilton's tutoring, much additional reading, and patient iristruc-
tion fr9m Do. Hodges, I learned a great deal about penetrating radia-/
tions.
Perhaos it was this background that had led Hodges, Dick, and
Rrbertson to suggest that I handle the health hazard problems in the
Office of Scientific Research and Development Project in the physics
department.
Conferences with Wollan and Hilberry and others continued. Fanally,
since it was not clear to me just what their research project was all about
and I felt I needed to know more if I were to be effective. I asked for
more specific information. Hilberry administered the oath of seerecy,
and after I had taken ia, he said, "Suppose you read this paragraph in
this physics text:": He handed me the book, arid there, in esseti.ce, it
stated: "If some morning you should awaken and find half the world
blown away, you will know that a nuclear fission chain reaction has been
accomplished " Realizing the possibility that a devastating instrument of
war-an atomic bomb--was the objective of this project was an over-
PersJrwrn-es rn Beolagi and .Nrdutn. WinUr 1981 I 197
I

Hlc12290041
whelming experience. 1 know I blanched; I know I had a bump in my
throat, and for a frtoment at least I was speechless and at the point of
tears. To find mysi'lf involved in the effort to split the atom in an atomic
pile, and in the awesome codsequences were it to succeed, hit me with
my hands down. I realized that by now I was inextricably involved, and I
already felt 5 years older.
The secret remained with me until one day in August 1945, when,
early in the morning, I called my wife and said, "You've been wondering
what I've been up to these several years. Turn on the radio-get a
newspaper." That was the day of Hiroshima with its dreadful
consequences-dedth and morbidity, sickness, destruction, and a lasting
question of morality.
Health C,onsideratiores for th,e ScientiJu Personnel
More briefing .4as forthcoming from Hilberry, Wollan, Edward
Creutz, and others, and at each briefing the magnitude and the serious-
ness of the health hazards to all scientific personnel from penetrating
radiations and from the many radioactive atoms produced in fission
became more obvious and more alarming. I
It was clear that 2s a physician I first had the duty of arranging space
to examine all employees of the Met Lab. No one escaped a thorough
physical examination, a urine test, and complete blood counts. I recall
personally examining many of the great experimental and theoretical
physicists and chemists, including Fermi, Teller, Franck, Hogness,
Zachariasen, Szilard, Zinn, and Seaborg. 1 found out which of them had
a wooden leg by simple inspection, not by failing to feel an anterior or
posterior tibial pulse. I found that there was only one woman physicist
among all these intellectual giants. She was Leona Woods, a young,
brilliant. and beautiful person who has recently written an account of
her experience on ihe Manhattan Engineer Project. [See book review in
this issue. Eotrott.) Local professional help was mobilized for exami-
nations because scientists, technicians, guards, and secretaries came to
Chicago by the hundreds. We had to set up individual schedules for
inieial and repeat exams for each individual, depending on his or her
work area, and on the potential exposure to penetrating radiations,
radioisotopes, and toxic chemicals each might receive. To facilitate all
this, we had a.special area set aside for physical exams, with specific
appointment times that we adhered to rigidly. Could you imagine ha:ing
Enrico Fetmi, and especially Ixo Szilard [1), wait for an hour in the
clinic? The same procedure was used for the laboratory exams. Mrs.
Edna K. Afarks, a nurse and superb lab technician whom I hireda was in
charge, and we gathered many more experienced technicians. '
Why did we doo so many repeat histories, physical exams, and lab
198 1' Lron O. farnAcon From Atom to Eve

w KM2290042
exams? Simply because, at that time, there was no way of mass-
monitoring radiation exposure, except by observing changes in the skin
and in the blood count. A fall in the white counts, and especially a
reduction in lymphocytes, was the most sensitive and reliable biologic
evidence of exposure.
However, this problem was tackled promptly by a group of the old
cosmic-ray physicists, including Drs. Volney Wilson, Wollan, Jesse, and
Shonka, all of whom were experts at radiation detection work. With the
machine shop's production efforts, badges with sensitive photographic
film, pocket electrometer dosimeters, and a variety of radiation detection
meters became available. With the availabifity of monitoring equipment
it became possible to recruit radiological physicists, such as Rose, Mor-
gan, and Parker. under whose leadership an effective health physics
monitoring system was established.
Feasibility Studies
At this point you tqight well ask, "Why did the decision to involve
medicine and. biology not come long before 1942? Why weren't in-
formed physicians and biologists consulted during the period when
feasibility studies and the many committee meetings of physicists,
chemists, and engineers were going on?"
Perhaps I can best answer this question by stating that it took in-
numerable experiments to determine whether a sustained controlled
atomic reaction could, in fact, be achieved. Could natbral uranium be
produced in a pure form and in a sufficient quantity so that a pile could
be built? What material would be used to slow down the fast neutrons
and to enhance their capture by uranium-235? As we now know,
graphite was found to have acceptable characteristics for this purpose.
By the end of 1941, small amounts of money (in the tens of thousands
of dollars) had been authorized and used for various studies related to
the ultimate goal of an atomic bomb. It was not until December of 1941
and January and February of' 1942 that decisions emerged, one after
another, involving the president of the United States and his advisors.
These advisors included many individuals, some of whom were on the
University of Chicago faculty: Fermi, Compton, Szilard, Allison, Bush,
Conant, Sachs, Einstein, and many others. The decision was made to
proceed with all haste, with not just one approach but several, to the
production and separation of' fissionable material [2J. There was the
uraniurn-235 gaseous diffusion separation work being done at the Uni-
versity of Californi.a~ Berkeley. And there was the plutonium production
work at the Univetsity of Chicago. The isotope separation projects
ended up with production plants at Oak Ridge. The plutonium work
moved from the natural uranium graphite pile under the stands at Stagg
Persqrciaes in Biotogy and Medinru Wintrr 1981 1 199

HKS2290043
Football Field to a pilot plant operation at Oak Ridge and the final
productain facilities at Hanford. Washington. The decision to proceed
with an all-out approach was related to the fact that there was reason to
believe that Germany was involved in a similar program and might be
well ahead of us.
During the last half of 1941, these working on the project became
reasonably confident. but still were not sure, that a chain-reacting pile
could be achieved. The same was true with the other projects involving
different approaches that were being tried elsewhere. Experiments done
in the late fall of 1941 and early January of 1942 made success appear
much tneire likely, and the decision was made in Washington to locate
the first experimental pile in Chicago under the direction of Arthur
Compton [2]. By early February 1942. Fermi, Szilard, Wigner, ~llison, Wheeler,
Breit, Mialliken, Manley, and their co-workers were either in Chicago or
on the way. Shortly, this core of physicists was joined by a similar cadre
of cheniists-McCoy, Spedding. Franck, Seaborg, Johnson, Boyd,
Coryell, and Burton and co-workers--and by thf key engineers, Tom
Moore and Miles Leverett. The Metallurgical laborAtory was rapidly
assuming at least a semblante of effective organization under such
leadership, and its professional and operational staffs wcre growing
almost explosively in the early months of 1942.
The Metallurg'ual Z.aboradory
When I asked Norman Hilberry how and why the Chicago operation
got its name, he responded:
The decision to name the project the Metallurgical Project and the laboratory
operation at the University of Chicago the Metallurgical Laboratory was made as
a sec urity measure to cloak its real nature. There !tad been casual talk for years
that, since metropolitan Chicago was a center for the metallurgical industry, the
University should recognize some sort ofohligation to it establishing a Metals
Institute. Here was the chance to fulfill that obligation an effectively hide what
was actually going on. No one would have bVlieved in January 1942 that this
obvious project in physics and chemistry would, within six months, be hiring
metallurgists like mad in order to solve the really crucial problems being faoed in
the design of production piles.
MEDICAL ASPECTS
While my initial assignment to the project came as a result of COmp-
ton's long research experience in the field of X-rays and consequent
realization of the health hazards involved, the true immensity of the
problems was not recognized at the stan. I was the lone physiciam
scientist on the project staff in February 1942, and II believe I was the
200 1 l.nm O. Jamb.+on ' From A+om to E-

HN92290044
first to be officially a part of any of the related nuclear weapons projects
[3J. (The only possible exception was Joe Hamilton in Berkeley, and I
don't think he was in then.) In April of 1942, this situation changed
suddenly and dramatically.
Norman Hilberry told me that, at that time, pile design had pro-
gressL-d to a point where the shielding design group became deeply con-
cerned with, the magnitude of the radiatiotrt control problems posed by
the core of an operating nuclear chain reaction pile. Not only was the
radiation generated enormously greater than anything ever experienced
before; bnt hundreds of new radioactive isotopes would be formed
which would have to be dealt with in the chemical processes required to
recover plutonium from the irradiated uranium. In priorexperience, a
10-gram radium source was about the most intense radiation emitter for
which there were valid biological and medical data. The intensities being
computed for the, core of an operating production reactor were the
equivalent of thousands of tons of radium, some hundred million times
greater. Hilberry said that Creuu came into his ofTice one morning in a highly
agitated state. He first broke the news about the magnitude of the radia-
tion health problem and then pointed out the imperative need, not only
to monitor present staff and future operations personnel, but also to
gain a far more profound knowledge and understanding of the interac-
aon of radiation with living systems and of the behavior of radioactive
isotopes introduced into Gving systems than existed at the time. Hilberry
passed the word on.to Contpton. Both had realized that there would be
radiation problems, but both were startled at their magnitude. Compton
immediately assigned Hilberry the task of getting an active biomedical
program under way.
It was clear that such a program would have to go far beyond supervi-
sion of health surveillance. It would have to undertake the study of the
biological effects of fission products-fast and slow neutrons, gamma
rays, X-rays, beta rays--and the even larger problem of many fission
product radioisotopes that are the by-products of the fission chain reac-
tion which produces plutonium, the element that the whole Metallurgi-
cal Project was about. (It had been estimated even in 1941 that, if but a
very few kilograms of plutonium were produced and purified and if
fission by fast neutrons could be induced, an explosion with a destructive
power equivalent to that of some tens of thousands of tons of TNT was
possible.)
INCREASING THE STAFF
As the outlines of the necessary biomedical program became dear.
Compton approached the selection of personnel in a rather unusual
PPrVlAVPS tn BIDIOgy QMlI AJP1tf7RP ' WMtPI 1981 1 201

NK®2290045
>
I
i
i
.
way. He already had me in place, and my show was in operation. It was
rumored that Cotnpton had invited, or, shall we say, !rers'uaded, two
individuals to join the Met Lab in 1942, each of whom thought he was to
be head of the health and biology program. He more or less simulta-
neously invited both Dr. Kenneth Cole and Dr. Robert Stone. Hilberry
recalls,
Creutz and others, as you might well guess, were demanding that a biophysicist
head the project to ensure adequate appreciation of the radiation effects. Ken
neth Cole's name came up. He was one class behind me at Oberlin, where his
father was dean of men. I knew him tiery well. Compton ok'd the choice: I got
Cole on the phone and he came out. He and Compton had a long session, and
Compton hired him. Cole had properly stressed that he could not be responsible
for the medical aspects. Gompton got to thinking about this and realized that
medical credibility was not only going to be essential for the health surveillance
activities but would also have to be part and parcel of the whole radiobiological
prograni. So he called Stone. Stone came and Compton persuaded him to join
up. After Stone left, Compton opened the door from his office to mirle and said.
"Norman. I seem to have hired two men for the same job. Will you please
straighten it out?" In wartime it worked.
Stone, Head of Radiology at the University of California, San Fran-
cisco, had collaborated with F.. O. Lawrence in using fast neutrons gen-
erated in the Berkeley cyclotroc tp treat a variety of diseases such as
cancer and severe arthritis of the spine., Blood counts and other tests had
been done on these patients. Later in 1943 and 1944, as these exposures
continued, Stone asked me to review the case histories and to see some of
the patients, but primarily to examine carefully the effects of the fast-
neutron therapy on the blood and blood-forming tissue of the necipients.
The damage to some of these patients was severe, and the trial with fast
neutrons was discontinued. Only in the past few years has interest in the
use of fast neutrons been revived, and several medical centems in this
country, including the University of Chicago, are again conducting trials
with fast-neutron therapy.
Cole, a physicist, had spent years working on nerve conduction and
other problems in biology that required a physicist-biologist type. At
Columbia, he had collaborated with Ross Golden on calibration of X-ray
therapy nta,hittes and related equipment.
Here, briefly. is part of Cole s account of his Chicago experience
(taken from (4) and a personal communication).
I got a call to come to C'.hicago for consultation. Compton and Hilberrjr told me
the story of nuclear fission and demanded that I take charge of the biomedical
problems. I knew at least how to start after convincing them I could arld would
not take the medical responsibility. It was an exciting 4 years; we grew exponen-
tially to a biology~ staff of nearly 400 before splitting in part to Site X. Oak Ridg,e.
It took 6 months to get our lab in operation in a lysoli7led stable of an extinct tce
202 1 Lro>r 0. fQroGion from Atom to F.re

HK®229004b
f
I
plant south of the Midway, called site B, and it was expanded twice. We had
cyclotron-produced radioisotopes and the availability of 250 kV X-ray machines
for radiobiologic studies; but that was it until I got one of the first practical hunks
of uranium2J8 from Spedding just before the Stagg Field pile went critical.
Then the Corps of Engineers took over and the battle for survival of a truly
biological pn,gram began with General Groves on the one hand and tuPont on
the other. I'U never forget the time when fission products became available and
George Svikla and I decided to try a radioautograph for fission product dose.
An exposed guinea pig was frozen, sawed into thick sections, and reassembled
with X-ray him between sections. Svikla watched'as the machinist cut the guinea
pig in slices using leaded gloves, etc., and then carefully replaced the band-saw
blade. I stole H. J. Curtis from a Hopkins Aviation project, and he later became
my counterpifn at Site X, Qitk Ridge. Everything was all tightly programmed, but
after Hiroshima and tiagasaki, the Chicago radiobiology program all blew up as
the Argonne, National Laboratory came intu being. Everyone had his pet hate
that he kept to himself until the war was won. War is so disgusting, so futile.
Simeon Cantril, a radiotherapist, was brought here by Stone from
Swedish Hospital in Seattle. He recruited Dr. Nickson and Dr. Margaret
Nickson to collaborate with him, not only on health effects monitoring,
but also on programs he initiated at Sloan-Kettering in New York, at
Michael Reese Hospital, and at the University of Chicago on the effects
on man of various doses of whole-body X-irradiation. At that time, X-ray
therapy was used almost exclusively for treatment of localized areas of
the body. Dr. Albert Tannenbaum was asked to and did initiate a com-
prehensive program on uranium toxicity in rodents at Michael Reese
Hospital.
I have made reference to the rumor that Stone and Cole each came to
Chicago thinking he would be the director of biology and medicine; but
it all turned out well without any obvious friction. Cole became head of
all biological investigations: Cantril, after working for a time in Chicago,
went to become Head of Industrial Miedicine at the Oak Ridge Labora-
tory, and I became Associate Director of Biology and Medicihte under
Stone, He and I shared a small suite of offices in Eckhart Hadl, where
Compton's office was located.
Also invited to join the Met Lab was Ray Zirkle, a radiobiologist from
Indiana University in'Bloomington, who brought with him several of his
colleagues and graduate students, including Eric Simmons and Charles
Hagen, Drs. Zirkle and Simmons. Edna Marks, and I teamed up on
many studies, but our principal collaborative study was a project on the
comparative biologic, effects of these penetrating radiations. Zirkle and I
had rabbits and mice in the uranium pile room before. ,;uring, bnd after
the atomic reactor in Stagg Field went ctitical. These animals were mon-
itored at ftrquent intervals for blood count changes, just in case physical
monitoring failed. Both Zirkle and I have often told this story, partly to
indicate that there was biological monitoring, but always adding the
Prrsprrtim in Biotogy and Medirme Winter 1981 1 203

HK®22900Q7
fabricated story that, since no biological changes were noted in the ex-
posed --bbits and rodents, we sacrificed and ate half of the control
rabbits because of the existing meat shortage.
To accommodate the expanding medical and laboratory examina-
tions, we acquited, in late 1942. a three-story building called then the
Maude Slye Building, which was adjacent,to Billings Hospital but has
since been torn down. Later Dr. J. Garrott Allen took over the supervi-
sion of the Metallurgical Laboratory Health Clinic and became active as
well in the study of the effects of pehetrating radiations on blood coagu-
lation. Temporary buildings were constructed on the north campus for
plutonium chemistry, inc(uding separation of Rhis~ element from the
fission mixture, and for other chemical studies related to the original
objectives. The Jones Chemistry Building was used initially and has be-
come a national monumedtt because a great dea.W of the early work on
plutonium was done there by Glen Seaborg and others.
The Ajte>rna!h, of December 2, 1942
When the great historical event occurrhd in Stagg Field on December
2. 1942. all systems were go. Plans for pilot plutonium reactors at the
Argonne Forest Laboratory and at Oak Ridge were under way, and
plans for large-scale plutonium production reactors to be located in
Hanford. Washington, were progressing. At about this point, the Army ,'
Corps of Engineers under General Groves took over. The whole opera-
tion, including the medical division Faere in Chicago as well as Oak Ridge,
remained a civilian operation under the Univetsity of Chicago. but we
were all reporting to the Army Manhattan Engineers. Colonel Stafford
1S'arren, then of the University of Rochester, and Captain Hyman
Friedell were the Army medical representatives, with whom we were in
frequ,ent contact.
Since the various plants were to become operational, it became a
necessity for Chicago to be a training ground for almost every aspect
related to the eventual goal of producing the plutonium for atomic
bombs. We conducted hundreds of experiments on fission products,
including lethal ranges, general metabolism in the body, localization of
fission products in the body, methods of reducing the body burden of
these radioactive atoms, and treatment of any overexposure, whether it
be from external sou;res or from ingested, inhaled, or injected fissiun
products. Dr. J. Nickson supervised the administration of mintite quan-
tities nf plutonium to two patients who had terminal cancer in order to
study its behavior in man and to make analyses for Pu bvdy burden
possible (5).
Mrs. Marks atfd I personally trained most of the medical technical
personnel and helped, set up the medical labs at Oak Ridge and Han-
204 I L~rn U. farnF+rr. From Atom to Etv

HK@2290048
I
,
ford. With Dr. Egon Lorenz, I was deeply involved in large-scale ex-
periments at the National (ancer Institute (NCI) in Bethesda. Maryland.
The NCI eaperinpents had a single objective.-the lifetime exposure of
groups of inbred mice and guinea pigs to daily doses of 0.1-8.8
roentgens. The purpose was to determine whether the then accepted
permissible dose of 0.1 roentgen per day was indeed safe. We monitored
the incidence of cancer at these levels and the effect on the,peripheral
blood. Orher general clinical and pathologic effects that might obtain
were monitored and involved the collaboration ot Walter Heston.
Thelma Dunne, M. Shimkin, Margaret Deringer. Allen Eschenbrenner,
and J.tne Doniger. among others. The lowest dose, 0.1 roentgen per day,
produced no statistically significant changes in the peripheral blood
counts of the animals. but ovarian tumors developed in many of the
female mice after several years of exposure [6j. All the other doses.
which tvere higher than 0.1 roentgen per day, produced significant ef-
fects on the blood counts and greatly increased the induction of ttpnors.
It was an exciting time. I had to travel considerably because of my
involvement with research at the Cancer Institute in Bethesda and my
supervisory and consultation responsibilities in the medical labs on the
Chicago campus and at Oak Ridge and Hanford: It was an unforgettable
experience to be present when the first large pilot plutonium plant went
into operation in Oak Ridge and when the first massivee plutonium re-
actor plant went into operation at Hanfor-4. Almost equally breathtaking
was the first visit to the huge plutonium separation facility in Hanford
that received the "hot" uranium rods when the fission process of the
U-238 had reached a plateau. By a simple yet ingenious remote-control
method, the purified pltttonium was separated from the other by-
products of fission. These hundreds of radioactive isotopes were a nui-
sance in one sense, since the only objective of the project was to recover
plutonium. But everitually some of these by-products became a boon to
biology and medicine.
In early 1943, wheh plans were well under way not only.for plutonium
production and separation but also for other methods for the separation
of U-235 under Harold Urey and E. O. Lawrence, we at Chicago were
still recruiting scientists, technicians. and other supporting personnel for
our biomedical stafl: One incident related to recruitment of scientific
medical staff members continues to amuse me whenever I think of it. Dr.
Compton knew Cecil J. Watson, head of medicine at the University of
Minnesota-probably through Watson's connections at NCI, of which
Compton was a director. He talked to m,- and Stone about recruiting
Watson. I had known Watson through medical circles, but also because
he had done some work on the effect of pelvic X-irradiation of women
with genital cancer. I-le had not only studied their blood counts and
found that they developed leukopenia and anemia, but he had also
I
PrrsP-lmrs in Btolo~ ernd Sfedvinv Winrrr 1981 1 205

HK12290049
>
uncovered some unusual new findings relating to porphyrin
metabolism. We agreed that it would be a plus if we could get him full or
part time. Since Watson was a VIP type, University of Chicago President
Robert Hutchins invited him to dinner. Watson had agreed to spend
every third week in Chicago on the condition that he could bring several
associates to Chicago and set up a program on the effects of radiation
and other noxioios aubstances on porphyrin metabolism. In discussing
this and trying to persuade Wats~on to come, Hutchins told him at dinner
what the Met Lab uas All about and that it was absolutely essential that we
have here a prestigious man of medicine known the world over for his
clinical acumen and his great research accomplishments. "Dr. Watson,"
he said, "you've just got to join us-we need you. All we have in medicine
and clinical research is a radiologist from California" (that was Stone)
"and a damned young intern from Billings" (that was L. O. Jacobson).
Since I wasn't at that dinner, h had no chance 'for rebuttal. Watson
thought that statement by Hutchins was so funny that he told me the
story.
I had gotten to know Robert Hutchins very well because of many
conferences in his office about problems involving matters of space and
personnel recruitment or just to,give him information on our progress.
One evening. I was at a private dinner with Hutchins and others. At the
proper tifne, whecn he and I were chatting and drinking in one corner of
the room, I said. "I understand that the way you finally got Cecil Watson
to join us was to tell him that you were extremely worried since the only
physicians you had were a radiologist from California and a damned
young intern frorqt Billings." His reply came without hesitation: "Yes,
Jake. that sounds like something I might well have said "
Progress reports front all pans of the project were required. Some
were prepared every day, others were expected at less frequent intenals.
Robert Mulliken was in charge of the information service-all docu-
ments went through his office. He had the able assistance of Hoylande
Young. Herman Fus"sler. and others. Eventually these thousands of
documents were the basis for a permanent record called the National
Nuclear Energy Series [3]. 1 mention this part of our activity as a re-
minder that there was a time when even more progress-report writing
was required than today. Therefore. I am amused by the discussions I
hear and the editorials I read on the awful chore imposed on researchers
who must spend so much time applying for and reporting on work they
are doing under government and foundation grants.
Hutchins brought Lawrence Kimpton to the university in 1943 as
business administrator of the Met Lab. He had his office in Eckhart. His
worries and problems involved vast Chicago enterprises on campus and
at the new Argonne Forest site, management of Oak Ridge (Site X), and
responsibility for many other large subcontracts. How could he help but
206 1 Lrop O. farobnn - From Alom to Evr

HK82290050
worry. since he was not only dealing with the army (General Groves) and
private industry, but also with a very large number of prima-donna
academic types on campus cdllected from universiiies the country over
as well as from Canada and England% Some years after the war, Law-
rence Kimpton became chancellor of the University of Chicago.
While Enrico Fermi. Szilard. Wigner, Allison, and other colleagues
worked on and finally achieved a self-sustaining pile and then.were
occupied with the thousands of problems involved in the planning and
building of pilot and production piles at Oak Ridge and Hanford, what
was Mrs. Fermi doing-- Well. I can tell you what she was doing a good
part of the time. She was a nurse's aide in my clinic. Even with my.Met
Lab responsibilities. 1..as the head of the Section of Hematology at the
U'niversity, so I had a clinic and a hospital service independent of the
Met Lab. Health Service. There Mrs. Fermi worked with me for a
number of years. She had a natural outward beauty, as well as an inward
beautv that was apparent to all of us. Our patients loved her; , her face
radiated peace, love. and hope.
The secrecy surrounding Met Lab activities somehow became a part of
one's being. Wives and friends and non-Met Lab scientific colleagues
didn't seem to be pushing for information. Almost the entire scientific
community was involved in one aspect of war work or another; perhaps
they were too preoccupied with their own tasks and their own adherence
to secrecy to be overly concerned with the Met Lab. even with its obvi-
ously enormous size in terms of space and manpower.
Meetings were often held during the day in the Eckhart Hall con-
ference room near Compton's office, attended by the leaders of vatious
aspects of the project's efforts. These meetings Hrre held for discussion
of progress and exchange of ideas. Attendance was largely confined to
individuals such as Fermi, Szilard, Hilberry. Franck, Spedding, Sea-
burg. Wigner. Allison, Doan, and others who had crucial responsibilities.
Latimer or one of his staff at the University of California and Chipman
or one of his staff at MIT would come in and report quite frequently.
Either Stone or I or both attended most of these meetings since it was
essential that we, have a reasonable grasp of the real and potential health
hazards that were emerging. Occasionally meetings were held in a class-
room at Eckhart or in Rosenwald at which a larger number of the scien-
tists from various sectioris of the project were p.resent. At these meetings,
Compton or General Groves would stress the urgency of the mission and
give some general information on the cutrent status of achievin;'their
goals. General Groves actually teased the Met Lab personnel on occasion
by suggesting that other niethods of obtaining pure fissionable material,
such as the electromagnetic separation of U-2S5 being carried out at Oak
Ridge, might succeed before the Chicago group working with DuPont
would achieve large-scale plutonium production and separation.
Prr*prtisvs fp Brofop ond .Nediriru tt'intar 1981 1 207

N R12290051
Some people who attended these meetings in Eckhart and in Rosen-
wald were extremely worried lest the relatively few guards at the doors
might be overcome by saboteurs who, with a few hand grenades or other
methods. would destroy the leadership of the whole Chicago program.
For example, the late Dr. William Bloom, a distinguished member of our
faculty. was extremely concerned not only about security in terms of
spying and careless leakage of secrets but also about sabotage. When he
came to visit me in Eckhart, he asked me more thau once whether I was
certain that the offices weren't bugged.
Of the many war-related research projects that existed on campus,
some were clothed in secrecy; others were less restricted. The toxicity
laboratory, directed by Dr. Franklin McLean, was a large research oper-
ati,on under the auspices of the Army Chemical Warfare Service. Dr.
John Hutchens, who later beuhme director of the Toxicity Laboratory,
was deeply involved in this program. A number of Met Lab personnel
had access to the Toxicity Laboratory's work on war gases. This conta..t
was important to our work on atomic energy, since the biological effects
of some of the war gases mimicked those of radiation.
RESEARCH ON NITROGEN MVSTARDS
E. S. Guzman Batrnn, a biochemist in the Department of Medicine,
wds interested in the effect of penetrating radiations and chemical war-
fare agents on enzyme systems and protein synthesis. He wrote a secret
report, to which I had access, on his observation that nitrogen mustards
as well as irradiation had an inhibitory effect on protein synthesis in
vitro. He also observed that this effect could be reduced by the addition
of glutathione to the mixture. After the war, Harvey Patt, who worked
here in the Met Lab during the war and moved to the Argonne National
Laboratory, reported the important observation that this class of chemi-
cal compounds, when given to laboratory animals (mice and rats) before
thky were irradiated, markedly reduced the mortality of recipient ro-
dents, even after exposure to doses of X-radiation that were in the lethal
ra nge.
My interest in war gases was stimulated by Barron, but especially by
the work of Dr. Clarence Lushbaugh and his colleagues in the Toxicity
La~,b. Lushbaugh was concerned with morbidity, mortality, and general
pathological effects of HNz [methyl-bis (P-chlorethyl) amine hy-
drochloridel. The effect on the blood and blood-forming tissue was an
important pan of his observations. At a secret seminar one afternoon in
January 1942. Lushbaugh suggested to me that he and I should try this
nitrogen mustard on patients with cancer of the blood (leukemia,
Hqdgkip's disease, etc.). On the basis of 'his data on mice, rats, and
rabbits, and his continuing counsel, we finally decided that a dose which
208 I l.ran O. Joro6ion F'rom Atnm tu Etr
J

HK12290052
was safe (in terms of mortalitj), but large enough to damage blood-
forming tissue, was in the range of 0.1-0.2 milligrams of HN2 per kilo-
gram of body weight. This compound is unstable when dissolved in
water or body fluids. It changes rapidly to a form that has relatively little
biologic effc~t. Accordingly one dissolved the material in water or saline
and injected it immediately IV.
In early March 1943, the first patient was selected for trial. He was a
patient with lymphatic leukemia who had failed to respond adequately to
radiophosphorus and X-ray therapy. I received the HNz from
Lushbaugh. who weighed out the material on an ordinary balance. We
dissolved it in sterile saline and immediately injected it in the patient's
antecubital vein in the right arm. The dose was 0.1 milligrams per kilo-
gram.
It may be difficult for many to understand the deep concern one has
when one is giving an extremely toxic but potentially therapeutically
effective chemical to a patient for the first time. True, one has the ad-
vantage, in a deliberately planned human experiment such as this, that
the dose is controlleJ or calculated from experience with animals and
from knowledge of all the specific organ and systemic effects of a wide
variety of dose schedules. Human beings generally, but not always, re-
spond to a drug or to a toxic substance in a way similar to animais. '
Therefore the first trial is inevitably a time of great concern. Obviously,
to proceed with this cli,;i:.al trial, we had to obtain the permission of Dr.
George Dick, Chief of Medicine, as well as of Franklin McLean, the
director of the Toxicity Laboraiory. Dick was experienced as a clinical
investigator, and his cautious supportive role in the venture cannot be
overemphasized. The participation of Dr. Charles Spurr and Dr. Tavlor
Smith as part of the clinical research team was essential. LushbaugFi, with
hic vast biological and pathological experienre with the nitrogen mus-
tard gases in general and with the particular one we employed (methyl-
bis), was a constant observer and advisor and, in fact, must be credited
not only with the idea to p-cxeed but with invaluable suggestions on dose
schedules and possible toxic manifestations of the drug.
After I gave the injection, I remained with the patient for 24 hours.
Within 15 minutes the patient became extremely nauseated and for
several hours had severe vomiting: but about 8 hours after the itijection,
he was able to drink water, although he had no appetite. All vital signs
were normal and remained so. -fwo and 4 days after the first injection,
the same dose was repc ated. Each time severe nausea and vomiting
followed. But the high blood count came down, and the leukemia-
infiltrated lymph nodes and spleen became smaller. The patient defi-
nitely had a remission.
The first dramatic therapetltic effect came when we treated a patient
who had a classical case of Hodgkin's disease (a cance, affecting the
Prrsprrtrtes m BtologY mul.ltrdinur n'intrr 1781 I 209
r

HK®2290053
lymph glands). The patient had been treated repeatedly with the only
method available at that time, in 1943-X-ray therapy. The X-rays were
applied to the lymphoid masses whefever they could be found by palpa-
tion or X-ray examination. (Up until 7943. X-ray tYeatment alone was
rarely curative, but it did occasionally produce remissions for months or
years.) When X-ray therapy failed to produce a remission, the patient
ofter6 had daily spiking fever up to 104°, drenching sweats, no appetite,
and other symptoms related to more general tumor invasion of organs
and tissues.
We decided to give this patient an injekon each day for 4 days. Again
the dose was 0. l milligram per kilogram of body weight. The patient had
the usual nausea and vomiting after each dose, but within 6 hours after
the first dose his temperature returned to normal. The lymph nodes
grew smaller and eventually disappeared. The patient achieved remis-
sion. and he was able to return to work and live normally and happily for
many years. A spectacular therapeutic triumph like this did not occur in
every patient treated with HNs, but the combination of X-ray therapy
and ni¢rogen mustard was a tremendous step forward.
What I have just described involving HNs (methyl-bis (P-chlorethyl)
ami,rde hydrochloride] represents abrief summary of the first therapeutic
ttialof a particular mustard gas in the therapy of the leukernia-lymphoma
group of disease, an experience rerv helpful to our extensive work with
radiatimns and radioactive fission products. The cure rate for these
diseases has been greatly increased sinre 1913 because, over the years,
many new chemotherapeutic agents'have been added to the previously
available armamentarium. The cure rate for Hodgkin's disease today is
in the neighborhood of 75 percent.
As pointed out by Gilman [7], numerous laboratories were set up at
universities throughout the United States in the early 1940s to study
chemical warfare agents under the auspices of the U.S. Office of Sci-
entific Research and Development (OSRD). In late 1942 and early 1943,
Thomas Dougherty, working with the Yale group, administered one of
the nitrogen mustards (tris [P-chlorethyl) amine) to mice of the Gardner
strain that had lymphosarcoma He found profound regression of the
tuo'tor. Dr. Gustav Lindskog joined Drs. Gilman, Goodman, and
Dougherty in conducting a clinical trial using the tris compound on pa-
tients with a variety of malignancies who were in the terminal phase of
their disease. One of these patients had a lymphosarcoma, and a marked
reduction in the tumor mass was noted. Howevcr, as Gilman noted [7],
this group of basic and clinical imestigators abandoned further clinical
studies because of other pressing problems related to the war effort.
Id July of 1943, Dr. Milton N'interqitz called a meeting at Yale at
which I reported detailed clinical findings on the patients we had treated
at the University of Chicago by using a different nitrogen mustard,
namely, the "bis' form.
,
210 1 Lrun o. JarnM,m from Atom to ftw

1 NK12290054
Thus, the independent clinical investigations of the Yale group and
the Chicago group, each working with nitrogen mustards, but of differ-
ent chemical strvcture; became known to other investigators who were
engaged with chemical warfare agents under the wartime secrecy re-
strictions imposed on s,uch endeavors.
After this meeting, clinical scientists, including Uoyd Craver frottl the
Memorial Hospital in New York, referred patients with Hodgkin's dis- '
ease to me for treatment. Craver later came to spend some time with our
group in Chicago to familiarize himself with our results and our' pro-
tocols. He and others then began to use the bis compound in their own
chemotherapy prartice. Use of the tris compound was essentially aban-
doned, since its toxicity was greater than that of the bis form. As it
turned out, serendipity had played an important role in our Chicago
project; we had chosen the bis compound for clinical trial, and it became
the nitrogen mustard bf choice for years to follow. Since the research
work (biological and medical) was classified as secret, the charts of our
patients simply recorded that substancex had been injected at x time inx
quantity. I reported otir findings at the annual meeting of the Associa-
tion of American Physicians in May of 1946, and soon thereafter a
number of publications on the subject appeared [i;-10].
I:RYTHROPOIETIN RESEARCH
Lest you think that I abandoned working on radiation and radioactive
materials while doing the work on mustard gas, let me mention one
experiment done in 1943 that was the basis for everything I have since
done in the laboratory. It was a simple experiment. I had shown in 1940
that repeated injection of estrogens would increase ossification of the
bones of mice, but that any resulting reduction in blood formation was
compensated for by an increase in blood formation in the spleen: thus,
no anemia occurred. However, the extra medullary blood cell produc-
tion in the spleen, though significant, was not spectacular.
We now had available one of the most dreaded of the fission products.
eaSr, a beta-ray emitter. This radioisotope is physiologically interchange-
able with calcium. Thus, after being injected in mice, it is localized almost
exclusively in the bones. Hhere all of the formed cellular elementsof the
blood except lymphocytic cells develop. The cells produced in the bone
marrow are mainly red cells. polymorphonuclear leukocytes, and
platelets. A single dose of 2 microcuries of 88Sr per gram of body weight,
given intravenously to the mouse, completely destroys the bone marrow.
Unexpectedly, howevek; a dramatic finding came out of the experiment.
The mice whose bone marrow was destroyed did not become anemict
their platelet counts as well as their leukocyte counts went down but
remained high enough to prevent fatal hemorrhage or overwhelming
infection. What was the reason? The nature of the beast was revealed.
Prrs/wrtkws fn Biologt and.tfrdinne N'inter 1987 1 211

UK92290055
"The mouse spleen, a small urgaain the left upper abdomen that weighs
a few milligrams. took uter biooxf formation as quickly as this function
was destroyed in the bone marnow by radiostrontium (111.
tis) biolugy friends iuuldti t believe my findings, but those of us who
-were clinicians knew that this very thing happens spontaneously,
although rarely. in the human being. As a part of the natural history of
the disease called polycythcmia rubra vera (a disease in which the af-
fected individual makes more red cells than needed and ir. which the
blood becomes as tiiirk as syrup). a small percentage of the patients-
perhaps as many as 10 percent-develop calcification and fibrosis of the
bone marroa, but the spleen may take over blood formation, and this
provides partial to adequate compensation. We don't know why this
extramedullary production of, the blood elements doesn't occur in all
human patients who develop calcification and fibrosis of the marrow. We
don i know why it invariably happens in the mouse and minimally in
rats, rabbits, and dogs. We do know that, in embryonic life in practically
all mammats, the spleen, liver, and even a few other tissues are impor-
tant factors in fetal blood production. Shortly before or shortly after
birth in maq and in rodents, blood formation except for formation of
lymphucytes is taken over almost completely by the bone marrow.
The bone marrow destruction by 89Sr, with rapid splenic takeover of
blood fotmatiun, was an exciting experiment; but the questions it raised
immediately were: How did the spleen have enough sense to take over?
What was the nature of the message that instituted this splenic transfor-
mation? 'This question inuigued me and my colleagues and students,
and in the years that followed, we found some of the answers. We gave
adult mice a lethal dose of total-body X-radiation (1;000 roentgens), but
we surgically exterioriaed the intact spleen and shielded it in a lead box
during irradiation. These lethally irradiated animalc all lived. Not only
did the shielded spleen increase blood cell formation, as occurred in the
eaSr experiment, but blorxi formation in the bone marrow and tymph
nodes returned to norrnal within 8 days after irradiation. So, we rea-
soned that something from the shielded spleen was capable of prevent-
ing the death of lethally irradiated mice. Our next step was to give the
mice a lethal dose of X-rays to transplant small slices of splenic tissue into
the peritoneal cavity or to give intravenous injections of mashed spleen
or embryo liver suspended in satine. Again the irradiated mice survived.
To my knowledge, this was the first time that anyone h4 saved the life
of a lethally irradiated animal (12, 13J.
As other investigators studied these findings, the life-saving effect of
spleen shielding or the transplantation of spleen slices or mash was ex-
plained. The cells of the spleen that were shielded or the normal spleen
slices or the mashed normal spleen cells injected or transplanted into the
lethally irradiated mouse started colonization in the destroyed marrow
212 1 L'nn O. f oruhwn From Atom to Ere

HK02290056
I
and lymph nodes and reconstituted the entire bload-furming tissu!
quickly enough to prevent death [ 14-16].
Today these findings are applied not unly in people irradiated by
accident but also in patients to whom radiation or chemotherapeutic
agents, such as nitrogen mustard, are given to destrov leukemic infiltra-
tion of blood-forming and other tissues. The irradiation-chemotherapy
combination may so depress the normal blood-forming tissue that death
from hemorrhage or infection or both may ensue unless normal biood-
forming tissue from a compatible donor is injected into the patient and
blood formation is restored to a more normal level [ 17]. Additionally, it
has been reported that patients with ideopathic "aplastic anemia" will
occasionally respond fayorably to transfhsion of compatible blood-
forming tissue [ 18]. .
We still did not know. the answer to the question: How does the spleen
of the mouse that has had its bone marrow destroyed know that it should
stan to produce blood cclh? Our lah -ories worked on this problem,
and uncovered, after developing approp;iate assay methods, some of'
the mechanisms that control red cell formation 119). This process is
controlled by a hormone called erythropoietin, and its production is, in
turn, controlled by a simple relationship in the body between oxygen
need and oxygen supply. If oxygen supply is reduced as in the 89Sr
experiment by elimitiatiun of red cell production in the marrow, pro-
duction of the hortnbne erythropoietin is stimulated. The increase in
erythropoietin is the message that tells the spleen of the es8r mouse to
begin producing red celle.
Our laboratory also discovered that this essential hormone is pro-
duced primarily in the kidney [20]. The large number of investigations
and approaches being taken by countless scientists will eventually help us
to understand how to control formation of all the formed elements of
the blood.
PLIlTON1UM PRODUCTION PROCEEDS TO TRIAL STAGE
MeanNhile, work on the prorluction of plutonium proceeded at Han-
ford and theseparation of U-235 at Oak Ridge. Long'before the
amounts required for au atomic bomb were reached, the theoretical
work on how to construct a bomb with these elements was urnder way at
Los Alamos, New Mexico. The Los Alamos project under Oppenheimer
was managed by the University of California, Berketey, but it, toD, was
under military control. All of the laboratories were in close liaison at
high management and scientific levels, but activities at Los Alamos were
kept tinder stricter secrecy niles and controls than those at Chicago, Oak
Ridge, or Hanford. When plutonium and U-235 became available, many
experiments were done at Los Alamos in which the botnb components
/'rysprrtave tn BtoGr& mrd .1)rdrrnu n'intvr 198) 1 21 3

H K1229-0057
were "assembled" for studies of the rapidity and efficiency of the calcu-
lated geometry and other factors involved in an instantaneous (mi-
crosecond) buildup of fission in plutonium and U-235.
Finally, the amounts of plutonium from Hanford and the U-235
separation at Oak Ridge were sufficient to permit the first practical test
of an atomic bomb. Feupeople here at Chicago or at the other sites were
aware of the plans and date of the first test. In the Chicago Health
Division, only a very few, individuals, such as Dr. Stone. Dr. Brues, Can-
tril, and I, and some health physicists were aware that, on,July 16, 1945,
the first test was to occur at davbreak at Alamagordo in New Mexico.
Many of you have read, the reactions of the individuals who were present
and who were responsible for the work }hat brought this test to fruition.
No one could escape thinking about the potential political, economic,
moral, and ethical issues that would emerge once the first self-sustaining
atomic reactor became, a reality in December 2. 1942. The leadership
and supporting scientific personnel of the Met Lab became increasingly
aware of the seriousness of these issues as the development of an atomic
bomb became more of a certainty. It is a fact that a communication was
prepared by laboratory personnel. signed by many of the leading scien-
tists, and sent in July of 1945 to President Truman asking that every
possible effort be made to communicate with the Japanese and try to
persuade them to surrender and thus obviate the awesome consequences
of atomic bombing.l assume Ihat President Truman made such an effort,
but if he did, the effort fai:ed. The president made the decision to drop
the bombs on Hiroshima and Nagasaki.
I quote from the introduction of the report on "The Atomic Bombings
of Hiroshima and Nagasaki" prepared by the Manhattan Engineer Dis-
trict, irhich begins with a statement by the president`of the United States:
"Sixteer. hours ago an American airplane dropped one bomb on
Hiroshima. Japan. and destroyed its usefulnrcc to the enemy. That
bomb had more power than 20,000 tons of T.N.T. It had more than two
thousand times the blast power of the British Grand Slam, which is the
largcst bomb ever yet used in the history of warfare." The Manhattan
Engineers report then goes on: "These fateful words of the Presidet,t on
August 6, 1943r, marked the first public announcement of the greatest
scientific achievement it) history. The atomic bomb, first tested in New
Mexico on July 16, 1945, had just been used against a military target. On
August 9th. three days later, at 11:02 A.M., another B-29 dropped the
second bomb on the industrial section of the city of Nagasaki, totally
destroying 1-ti's square miles of the city, killing 39,000 persons, and
injuring 25.000 more. On August 10, the day after the atomic bombing
of Nagasaki, the,Japanese government requested that it be permitted to
surrender under the terms of the Potsdam declaration of July 26th
which it had previously ignored:" ,
214 I 1,., 0. farnG+on FromAlomloF.w
P
I
J

NK12290058
In theEnd
Thus the war ended. The Met Lab on campus rapidly became a part of
the Argonne Laboratory. Stone and dnost of the borrowed professionals
returned to the universities or corporations from whence they had come.
Iwas asked to become the director of health and biology during the
transition. I accepted, but fortunately Dr. Austin Brues took over in
1946 and remained the director at Argonne for many years that bridged
the passage of the Atomic Energy Act and the establishment of Argonne
as a national laboratory. I returned to my clinical and teaching duties
and began, together with scientists the world over, to exploit the newly
gained knowledge for restarch on what is often referred to as "Atoms
for Peace."
REFERENCES
1. LlBnv. L. M. The uranium people. Nex York: Scribner's. 1979.
2. S.yI-rH H. D. Atomic energy for military purposes. Princeton NJ.: Prince-
ton Univ. Press, 1946.
3. STO>,E. R. S. Introduction. In Industrial Medreine on the Plutonitim Project,
edited by R. S. STONE. NatL Nucl. Energy Ser. 4, vol. 20. Washington, D.C.:
Atomic Energy Commissuon, 1951.
4. CoLL, K. S. Mostly membranes. Annu. Rev Physiol. 41:1-24, 1979.
5. 1/cKso,%. J. Blood changes in human beings following total body irradiation.
In Indusnial ,bledicine on {he Plutonium Project, edited by R. S. Sroxr.. Natl.
Nucl. Energy Ser. 4, vol. 20. Washington, D.C.: Atomic Energy Commission,
1951.
6. LoaL%z E. Effect of longcmntinued total body gamma irradiation on mice,
guinea pigs. and rabbits. V I, Conclusions and applicability to the problem of
human protection. In Btologu EfJeds fj External X and Gamma Radiation,
edited by R. ZtRKLe. Natl.'.Vud. Energy Ser. 4, vol. 22B, Washington. D.C.:
Atomir Energy C:ommission, 1951.
7. GILSt,ue. A. The initial trial of nitrogen mustard. Am. f. Surg. 105:574-578.
1963.
8. Gtu.tAK A.. and PHIUPs, F. S. The biological amines and therapeutic appli-
cation of the jB (beta)-chloroethyl amine and sulfide. Srien<e 103:409415,
1946.
9. GoODS1A\ L. S.; WtNTROBE. M. M.: DAMESHEK. W.; GOODMAN. M. J.: GIL-
sfAn, A: and McLENNAN, M. T. Clinical experiences with the use of
methyl-bis (P-chloroethvl) amine hydrochloride and tris (PKhloroethyl)
amine hydrochloride (nitvogen mustards) in the therapy of Hodgkin's dis-
ease, l}mphosarcoma leukemia and certain allied and miscellaneous dis-
orders. fAbfA 182:126-132, 1946.
10. JACOBSON. L. 0.; SPL'RN, C. L.: BARRON. E. S.; SMITH, T.; Ll`SHBAItGH, C.:
and DicK. G. F. Nitrogen mustard therapy: studies on the effect of inethyl-
bis (beta chloroethyl) anJne hydrochloride on neoplastic and allied dis-
orders of the hematopoie,iic system. fA,tfA 132:263-271, 1946.
11. JACXIBSON. L. 0.: SIMMpNS, E. L.: and BLOCx. M. Effect of splenectomy on
toxicity of Sr89 to hematopoietic system of mice. J. Lab. Clin. Med.
34:1640-1655. 1949.
Prrslxetnrs tn BroloRs and.Sledinne N'intn 1981 1 215

HK92290059
12. JACOasoy. L.0.: MARtts. E. K.; GASTON, E. 0.: RossoN, M. a.: and 2t¢ttt.E.
R. E. The role pf the spleen in radiation injury. Pror. Sor. Exp. BioL Med.
70:740-742. 1949.
13. JACOBSON. L. O.; StMNoNs. E. L; MAtkRs. E. K.; RossoR. M. J.; BETHARD.
W. F.; and GASroN. E. O. The role of the spleen in radiation injury and
recovery. J. Lab. Clin. Med. 35:746-770, 1950.
14. LtNDat.EV, D. L.; ODELL, T. T.; and TavscHE. F. G. Implantation of func-
tional etythropaietic elements following total-body irradiation. Pror. Soc.
Exp. Biol. Med. 9Q:512-515, 1953.
15. Ne.wEtr., P. C.; CouE. L. J.' HABERMEYER, J G.; and ROAN, P. L. Growth and
continued function of rat houtemarrow cells on X-radiated mice. CancerRes.
16:258-261, 1956.
16. FoRD. C. E.; HvstERTON. H. L.; BARNEs, D. W.; and Lotrrn. J. R. Cytological
identification of qadiation-chimaeres. Nnltcre 177:452-454, 1956.
17. WEIDEN, P. L.; SCHUCTER. S. J.: and BANAp, M. Marrow transplantation for
aplastic anemia and leukemia: reviaw of results and blood product support
required. Prog. Clin. Biol. Res. 28;295-312, 9978.
18. CAnstrrA, B. M.: 'FHOMAS. E. D.; NATHAN, D. G., et al. A prospecove study of
androgens and bone marrow transplantation for treatment of severe aplas-
tic anemia. Blood 53:504-514, 1979.
19. JACOHSON, L. 0.: ~Got.DwA3sER, E.: GutttaEV, C. W.: FtttED. W.; and PtzAx, L.
Studies on erythropoietin: the hormone regulating red cell production. Ann.
N.Y. Acad. Sci. 77:551-03, 1959.
20. JACOBSSON. L. 0.;, GoctnvassER, E; FRtt:D, W.; and 1Pt~AS, L., Role of the
kidney in erythropoiesis. Nature 179:638-634,1957.
216 1 Leon o. Jorobwn Flom Aronr'w Ebe
